Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Cited by (7,499)

Items 6,801–6,900 of 7,499

1. Guidelines and Straitjackets: Blood Pressure Targets in the Era of the Eighth Joint National Committee
   Douglas Hurd · 2014
2. An Introduction to the Glom-NExT Inaugural Symposium: Toward Precision Medicine in Nephrology
   Anna Greka · 2016 · Seminars in Nephrology
3. Nefroprotekcyjne działanie antagonistów wapnia
   Danuta Czarnecka · 2006 · Jagiellonian University Repository (Jagiellonian University)
4. Renin-Angiotensin-Aldosterone System Angiotensin AT 2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension
   Luis Celso Matavelli, Jiqian Huang, Helmy M. Siragy · 2017
5. Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type
   Minglong Shao, Lechu Yu, Fangfang Zhang, Xuemian Lu, Xiaokun Li, Cheng Yun Peng, Xiufei Lin, Luqing He, Shunzi Jin, Yi Tan et al. · 2015
6. Europejskie zalecenia dotyczące leczenia nadciśnienia tętniczego: stanowisko Europejskiego Towarzystwa Nadciśnienia Tętniczego 2009
   Giuseppe Mancia, Stéphane Laurent, Enrico Agabiti‐Rosei, Ettore Ambrosioni, Michel Burnier, Mark J. Caulfield, Renata Cífková, Denis L Clement, António Coca, Anna F. Dominiczak et al. · 2010 · Arterial Hypertension
7. Serum Endothelin-1 Elevation in Diabetes. A Reflection of Pathophysiological Process or a Biomarker beyond Expectation?
   Behrouz Salehian · 2015 · International Journal of Diabetes and Clinical Research
8. NARRATIVE REVIEW Omega-3 Polyunsaturated Fatty Acids in the Treatment of Kidney Disease
   Robert Gordon Fassett, Glenda Carolyn Gobe, Jonathan M. Peake, Jeff Scott Coombes · 2010
9. Controle da pressão arterial de pacientes diabéticos tipo 2 e hipertensos nos serviços público e privado de saúde Blood pressure control in type 2 diabetic and hypertensive patients in public and private Healthcare service
   Daniel Panarotto, Michele Salibe de Oliveira, Lívia Brancher Gravina · 2010
10. The impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients
    Fanny Lepeytre, Héloïse Cardinal, Lorraine Fradette, Jacobien C. Verhave, Marc Dorais, Jacques LeLorier, Vincent Pichette, François Madore · 2016 · Clinical Kidney Journal
11. L’hypertension chez les diabétiques de type 2
    Norm R.C. Campbell, Richard E. Gilbert, Lawrence A. Leiter, Pierre M. Larochelle, Sheldon W. Tobe, Arun Chockalingam, Richard Ward, Dorothy Morris, Ross T. Tsuyuki, Stewart B. Harris · 2011 · Canadian Family Physician
12. Раміприл у пацієнтів з артеріальною гіпертензією як монотерапія або в комбінації з гідрохлортіазидом
    Yuriy Sirenko, О.L. Rekovets · 2017 · HYPERTENSION
13. Hypertension in Older Adolescents and Young Adults
    Arthur Eric Anderson · 2017 · Springer eBooks
14. Inhibition and reversibility of renal changes: lessons from diabetic kidney disease
    Allan Flyvbjerg · 2006 · Acta Paediatrica
15. Asians With IgA Nephropathy Have An Increased Risk of Progression to End-stage Renal Disease
    Sean J. Barbour · 2012 · TSpace (University of Toronto)
16. Gefäßprotektion durch Antidiabetika über die Glukosesenkung hinaus
    Thorsten Siegmund · 2017 · CardioVasc
17. Impact of Blocking Renin Angiotensin Aldosterone Axis in Acute Kidney Injury
    Shaimaa Nasr Amin, Noha Abdel Latif, Laila Rashed · 2017 · The International Annals of Medicine
18. Bedeutung der Blockade des lokalen Angiotensinsystems für die chronisch progrediente Niereninsuffizienz im Rahmen der Alport-Nephritis
    Sebastian Bemme · 2012
19. Angiotensin-Receptor Antagonists for Diabetic Nephropathy
    AS Brett · 2001 · Journal watch
20. A memória hiperglicêmica no rim diabético: marcas metabólicas, moleculares e epigenéticas
    Antonio Anáx Falcão de Oliveira · 2017
21. Untersuchung zur Verzögerung der terminalen Niereninsuffizienz durch die Therapie mit ACE-Hemmern bei Patienten mit Alportsyndrom in Belgien und Spanien
    Susanne Elisabeth Stietz · 2012
22. De Novo and Recurrence of Renal Disease
    Quirino Lai, Fabio Melandro, Francesco Pisani · 2017 · Elsevier eBooks
23. Chinese Herbal Medicine in the Management of Atherosclerosis-Related Chronic Conditions in an Aging Population
    Enoch Chan, Sai Wang Seto, Tsoi Ming Au Yeung, Gabriel Hoi Huen Chan · 2017 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
24. Was passt, was nicht?
    Thorsten Siegmund · 2017 · MMW - Fortschritte der Medizin
25. RAAS Blockade as First-Line Antihypertensive Therapy among People with CKD
    Panagiotis I. Georgianos, Elias V. Balaskas, Pantelis E Zebekakis · 2017 · InTech eBooks
26. Clinical Study to Compare the Efficacy of Triple Blockade with that of Double and Single Blockade of RAAS in Non-Diabetic Chronic Kidney Disease Patients
    Sushil Kumar · 2017 · Journal of Medical Science And clinical Research
27. OBSOLETE: Stage A Heart Failure: Identification and Management of Heart Failure Risk Factors
    Matthew Gregory Nayor · 2017 · Elsevier eBooks
28. Comparison between valsartan and valsartan plus cilnidipine in type II diabetics with normo- and
    Shogo Nomura, Hiroshi Ishikawa, Tomoko Murata · 2006
29. Renin–angiotensin–aldosterone system and the kidney
    Niren K Shah, Katie Vogel-Anderson, Rushab Choks · 2012
30. Overview of the Therapeutic Use of Angiotensin- Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Mineralocorticoid Receptor Antagonists, and Direct Renin Inhibitors
    Kelly Mercier, Holly D. Smith, Jason I. Biederman · 2014
31. Diabetic nephropathy—emerging epigenetic
    Rama D Natarajan · 2014
32. Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic
    Ellen D. Burgess, Jiang He, Giora Davidai, Stephen E. Koval · 2008
33. Diabète de type2 etfacteurs de risque cardiovasculaire
    Fabrice Bonnet · 2017
34. Diabète sucré ethypertension
    Bernard Bauduceau, L. Bordier · 2017
35. The Significance of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Use in Sudden Cardiac Death
    Makoto Onodera, Satoshi Kikuchi, Yasuhisa Fujino · 2017 · International Journal of Clinical Medicine
36. Hypertension: An Evidence Informed, Case Based Approach
    Andrew S. Mackie · 2017 · Physician Assistant Clinics
37. Why kidney disease always gets worse: what can we do about it?
    Christopher Y. Lu · 2014
38. Diabetes Mellitus in the Elderly
    Nages Nagaratnam, Kujan Nagaratnam, Gary Cheuk · 2017 · Springer eBooks
39. The effect of renin-angiotensin system blockades on renal protection in chronic kidney disease patients with hyperkalemia
    이주현 · 2013 · YUHSpace (Yonsei University Medical Library)
40. Lineamientos para el control de la glucemia y albuminuria en pacientes con nefropatía diabética en primer y segundo nivel de atención en Colombia. Panel nacional de expertos
    Adriana Guisella Méndez Medina, Carlos Olivares, Carolina Salinas, Carlos Rosselli, Rafael Andrés Barón, Diego Ocampo, Alejandro Pinzón Tovar, Oswaldo Rincón, Iván Villegas, Álvaro Fortich · 2017 · Alad
41. Effect of antihypertensive treatment at different blood pressure levels
    Mattias Brunström · 2017 · DiVA at Umeå University (Umeå University)
42. JNC 7: New Guidelines for the Management of Hypertension
    Patricia A Howard · 2003 · Hospital Pharmacy
43. Modifiers of the Kidney Response to Activation of the Renin-Angiotensin System: ACE2 and Adiponectin
    Fei Fang · 2014 · TSpace (University of Toronto)
44. Pattern-based Classification and Survival Analysis of Chronic Kidney Disease.
    Munevver Mine Subasi, Melissa Stradley Moreno, Travaughn C. Bain, Megan Moreno, Ersoy Subasi, Katherine C. Carroll, Emily Cunningham, Michael S. Lipkowitz · 2016 · ISAIM
45. Chronic kidney disease (CKD): the silent epidemic. The importance of early detection and treatment on the prevention of CKD (Derleme)
    Izzet Hakki Arikan, Mehmet Koç · 2005 · Dspace Repository (Marmara Üniversitesi)
46. Effectiveness of Carvedilol versus Indapamide in Uncontrolled Diabetic Hypertensive Patients being Treated with Olmesartan and Amlodipine
    Md Masud Hasan, AKM Mosharrof Hossain, Hussain Ahmad · 2018 · Medicine Today
47. Determinants of Hypertensive Renal Disease and Its Progression
    Karen A. Griffin, Aaron James Polichnowski, ANIL K. BIDANI · 2018 · Updates in hypertension and cardiovascular protection
48. Aldosterone Blockade Added to Renin-Angiotensin System Blockade to Reduce Albuminuria—A Path for Improved Renoprotection?
    Peter R Rossing, Frederik Persson · 2018 · The American Journal of the Medical Sciences
49. Renin–Angiotensin Blockade
    Domenic A. Sica · 2018 · Elsevier eBooks
50. Targeting Other Modifiable Risk Factors for the Prevention of Heart Failure: Diabetes, Smoking, Obesity, and Inactivity
    Timothy Gong, SHELLEY A. HALL · 2018 · Current Cardiovascular Risk Reports
51. Renoprotective effect of inhibiting renin-angiotensin-aldosterone system (RAAS) by captopril versus losartan on drug-induced acute kidney injury (AKI)
    Muhammad Zafar · 2018 · Pure and Applied Biology
52. Nephrologie: Proteinurie - «to screen or not to screen?»
    PM Ambühl · 2006 · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
53. Protéinurie, 2e partie. Approche diagnostique et prise en charge. Signification dune microalbuminurie
    V Bourquin, M Giovannini · 2007 · Forum Médical Suisse ‒ Swiss Medical Forum
54. Analyse organoprotektiver Effekte durch eine Barorezeptorstimulationstherapie zur Behandlung der Therapie-refraktären arteriellen Hypertonie
    Luca-Yves Lehnig · 2017
55. Primary and secondary prevention of arterial hypertension: nephrologist's point of view
    Simeone Andrulli, S. Mancuso, Maria Carla Bigi · 2012 · Giornale di Techniche Nefrologiche e Dialitiche
56. Diagnostic use of contrast medium and the kidney: A challenge or a ghost?
    Marina Foramitti, Bruno Perrucci, Stefano Panni · 2018 · Journal of Onco-Nephrology
57. STUDY THE NEPHRO-PROTECTIVE EFFECTS OF LOSARTAN ON RATS
    Hosny Elewa · 2014 · ˜Al-œAzhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences
58. Clinical Trial Examples
    Geraldine Rauch, Svenja Schüler, Meinhard Kieser · 2017 · Springer series in pharmaceutical statistics
59. An Overview on Diabetic Nephropathy
    Kei Fukami, Sho‐ichi Yamagishi · 2018 · Elsevier eBooks
60. Pharmacologic Treatment of Hypertension
    Domenic A. Sica, Todd W.B. Gehr · 2007 · Elsevier eBooks
61. Kidney Disease in Hypertension
    Kenneth L. Choi, George L. Bakris · 2007 · Elsevier eBooks
62. Studies on Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and p47phox-Dependent NADPH Oxidase and their Roles in Diabetic Nephropathy
    Chaojie Liu · 2012 · TSpace (University of Toronto)
63. “AQUI TEM FARMÁCIA POPULAR”: UMA AVALIAÇÃO DOS MEDICAMENTOS DISPENSADOS PARA O CONTROLE DA HIPERTENSÃO ARTERIAL NO ESTADO DA BAHIA.
    Êuder Reis Dias · 2018 · Saúde com
64. Update on renal disease in diabetic patients in primary care
    David Morris · 2018 · Independent Nurse
65. Fall 48: Therapie – 68 Jahre, ♀ und ♂ (Zwillinge), Albuminurie, Bluthochdruck
    Johanna Zemva · 2018 · Springer eBooks
66. Fall 20: Spätschäden – 58 Jahre, ♀, DM Typ 1, drohende Dialyse
    Lars Kihm · 2018 · Springer eBooks
67. Analysis of the Main Factors Affecting the Entrepreneurial Willingness of Science and Technology Workers in China
    Kang Li, Hui Shi, Dasheng Deng · 2018 · Portland International Conference on Management of Engineering and Technology (PICMET)
68. Role of Glomerular Mechanical Stress in the Pathogenesis of Chronic Kidney Disease
    Clarice Kazue Fujihara, Roberto Zatz · 2012 · Elsevier eBooks
69. (Clinical) Trial and Error in Diabetic Nephropathy
    Marjolein Y. A. M. Kroonen, Hiddo J.L. Heerspink, Dick de Zeeuw · 2018 · Springer eBooks
70. Post Kidney Transplant: Hypertension
    Vikram Patney, Fahad Aziz · 2018 · Springer eBooks
71. Microvascular Damage and Hemodynamic Alterations in Diabetic Nephropathy
    Eliane F.E. Wenstedt, Liffert Vogt · 2018 · Springer eBooks
72. Management of Hypertension in Diabetes Mellitus
    Michael N. Doumas, George L. Bakris · 2018 · Springer eBooks
73. Diabetes and The Kidney
    Raymond Clement Harris · 2012 · Goldman's Cecil Medicine
74. Initial Choices in the Treatment of Hypertension
    Myron H. Weinberger · 2005 · Elsevier eBooks
75. Progression of Chronic Kidney Disease and Renoprotective Therapy in Children
    Elke Wühl, Franz S. Schaefer · 2008 · Elsevier eBooks
76. Chronic Kidney Disease in the Primary Care Setting: Cardiovascular Disease Risk and Management
    Jay Ian Lakkis, Matthew R. Weir · 2018 · Contemporary cardiology
77. Iperkalemia cronica nei pazienti cardio – renali: q & a per il cardionefrologo pratico
    Luca Di Lullo, Claudio Ronco, Fulvio Floccari, Antonio De Pascalis, Vincenzo Bàrbera, Rodolfo Fernando Rivera, Antonio Bellasi · 2018 · Giornale di Techniche Nefrologiche e Dialitiche
78. Hypertension in type 2 diabetes mellitus
    Norman M. Kaplan · 2009 · Dialnet (Universidad de la Rioja)
79. ENFERMEDAD CARDIOVASCULAR EN PACIENTES CON ENFERMEDAD RENAL POR DIABETES
    Guillermo Dieuzeide · 2018 · Revista de la Sociedad Argentina de Diabetes
80. Pharmacologic Renal Protection
    Wael F. Hussein, Austin G. Stack · 2019
81. Prevenzione delle Malattie Cardiovascolari Work in Progress 2006
    Prevenzione delle Malattie Cardiovascolari · 2016 · Monaldi Archives for Chest Disease
82. Hypertension and the Kidney
    Rupinder K. Sodhi, Marie Philipneri, Paul G. Schmitz · 2019 · Oxford University Press eBooks
83. Systematic Review : Comparative Safety and Efficacy of Monoand Combination Therapy of Anti-hypertensive Agents Acting on the Renin-Angiotensin System
    Kyung Eob Choi, Hyun-Kyung Kim · 2011 · Korean Journal of Clinical Pharmacy
84. Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists on Residual Renal Function Preservation in Peritoneal Dialysis Patients
    Reyes Marin Fernando Arturo · 2019 · Journal of Urology & Nephrology Studies
85. Renin-Angiotensin System Blockers and Acute Kidney Injury
    Lucia Del Vecchio, Francesco Locatelli · 2019 · Elsevier eBooks
86. Blood Pressure-Lowering Treatment and the Prevention of Heart Failure: Differences and Similarities of Antihypertensive Drug Classes
    Costas Thomopoulos, Alberto Zanchetti · 2019 · Updates in hypertension and cardiovascular protection
87. The effects of losartan on central and peripheral blood pressure
    Jiri Widimsky Jr., Ondřej Petrák, Branislav Štrauch · 2010 · Cor et Vasa
88. Гиперкалиемия и хроническая болезнь почек
    S.V. Kushnirenko · 2019 · KIDNEYS
89. Kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions
    곽승재 · 2010
90. Das Herz beim metabolischen Syndrom
    , · 2004 · Kardiovask Med
91. Renal Disease in Diabetes
    Carlos A. Garza-García, Virgilia Soto Abraham, Magdalena Madero · 2019 · Springer eBooks
92. Treatment of Essential Hypertension with Emphasis in the Renin-Angiotensin System: How to Prevent Secondary Outcomes without Adding Fuel to the Fire
    Gabriel Lucca de Oliveira Salvador · 2019 · IntechOpen eBooks
93. FOOD AND LIVING HABITS OF DIABETIC PATIENTS TYPE 2 MONITORED TO DEPARTMENTAL HOSPITAL CENTER (CHD) ATACORA (BENIN).
    Christian T. R. Konfo · 2019 · Journal of Biomedical and Pharmaceutical Research
94. Efeitos da própolis verde brasileira sobre a proteinúria e função renal em pacientes com doença renal crônica: um estudo clínico randomizado, duplo-cego, placebo-controlado
    Marcelo Augusto Duarte Silveira · 2019
95. A Patient with Chronic Kidney Disease and Heart Failure with Preserved
    Zubair I. Shah, James Chen-Tson Fang · 2019 · Springer eBooks
96. Potential advantages of aliskiren, the first renin inhibitor Ventajas potenciales de aliskiren, el primer inhibidor de la renina
    José Antonio García‐Donaire, Luis Miguel Ruilope Urioste · 2009
97. Treatment of Patients with Heart failure and Type 2 Diabetes: a review of the literature
    Elisa Fabbri, Maurizio Nizzoli · 2019 · Italian Journal of Medicine
98. The short‐term effects of angiotensin II receptor blockers on albuminuria and renal function in Korean patients
    Juyoung Shin, Hun‐Sung Kim, T Kim et al. · 2019 · Basic & Clinical Pharmacology & Toxicology
99. Cardiorenal protection in advanced chronic kidney disease: research highlights from landmark papers published in Nephrology Dialysis Transplantation during 2018
    Panagiotis I. Georgianos, Rajiv Agarwal · 2019 · Nephrology Dialysis Transplantation
100. Outreach and Connection to Care for Chronic Kidney Disease in a Workplace Wellness Setting: A Cost-Effectiveness Analysis
     Yonghong Li, James J. Devlin · 2020 · Population Health Management